Can a Michigan resident get peptides by telehealth?
Michigan's telehealth provisions are in the Public Health Code, MCL 333.16283 through 333.16288 (2016 Public Act 359, effective March 29, 2017, with section 16285 amended by 2017 Public Act 22). A health professional must obtain consent for treatment, directly or indirectly, before providing a telehealth service (MCL 333.16284). Under MCL 333.16285, a professional providing a telehealth service may prescribe a drug if the professional is a prescriber acting within scope of practice and, for controlled substances, meets the controlled substance requirements. The prescriber must refer the patient to geographically accessible care when medically necessary and must be available for follow-up care or refer the patient for it. Board of Medicine rule R 338.2407 repeats these conditions and holds telehealth to the in-person standard of care. MCL 333.16283 says telehealth may include telemedicine as defined in MCL 500.3476. That section is in the Insurance Code and applies here only because MCL 333.16283 adopts its definition. The definition covers examining the patient by secure interactive audio or video or through the use of store and forward online messaging. Michigan law does not say whether a static questionnaire alone is enough. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as allowed because the statute lets a prescriber prescribe during a telehealth service and the definition it adopts names store and forward messaging as a way to examine the patient, and nothing in the statute or Board rule requires a real-time visit. [2] [3] [4] [5] [6]
How does the Michigan pharmacy board treat compounding?
| Board | Michigan Board of Pharmacy (Department of Licensing and Regulatory Affairs, Bureau of Professional Licensing) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Board of Pharmacy, housed in LARA, regulates pharmacy under Part 177 of the Public Health Code (MCL 333.17701 to 333.17780) and the Board of Pharmacy General Rules in the Michigan Administrative Code (Part 3, pharmacy licenses, R 338.531 to R 338.539, and Part 6, practice of pharmacy, R 338.582 to R 338.591). MCL 333.17748 requires a pharmacy, whether or not located in Michigan, to be licensed to do business in the state; MCL 333.17748e sets narrow conditions under which a licensed out-of-state pharmacy may deliver through a Michigan-licensed wholesale distributor-broker. After the 2012 compounding outbreak, Michigan enacted MCL 333.17748a (2014 Public Act 280, effective September 30, 2014), which requires a pharmacy that provides compounding services for sterile pharmaceuticals to hold current accreditation from a Board-approved national accrediting organization, or to show USP compliance in a manner the Board determines, to verify that status with each license renewal, and to notify the department within 30 days of a complaint from another state or a federal investigation about its compounding. Under R 338.533 the Board adopts USP chapters 795 and 797 (both revised 2023) as the compounding standards, and under R 338.534 an out-of-state pharmacy that will provide sterile compounded preparations in Michigan must have an inspection completed no more than 18 months before its initial or renewal application, by the department, a Board-recognized national inspection program, an approved accrediting organization, or its home-state licensing agency. Michigan has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [7] [8] [9] [10] [11] [12]
Can you get compounded GLP-1s in Michigan?
A telehealth GLP-1 program shipping compounded injections into Michigan must use a pharmacy that holds a Michigan pharmacy license under MCL 333.17748, which patients can check in the LARA license verification system. [1] [7] [15]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Michigan?
Access options
Prescriber licensed in Michigan, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Michigan. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in Michigan
What you'll actually find in Michigan, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [19] [20] [21]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [22]
What Michigan has done
PeptideAgent has not found a board or legislative action on peptides in Michigan.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [24] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [25] [26] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in Michigan. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. [2] [3] [4] [5] [6] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Michigan Board of Pharmacy (Department of Licensing and Regulatory Affairs, Bureau of Professional Licensing); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [23]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [22]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [13] [27] [28]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [23] [29] [30]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [21] [30] [31]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [22] [32] [33] [34] [35] [36]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [22]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [23]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [21]
- Pharmacy: Is this made for me on a prescription written in my name? [31]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [21] [30]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [21]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in Michigan?
Part 177 of the Public Health Code restricts the dispensing and sale of prescription drugs to licensed pharmacies and prescribers, and a seller of "research use only" injectable peptides to Michigan consumers holds no such license. [7] [16]
Peptide-specific notes for Michigan
No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.
Frequently asked questions
Can I get a GLP-1 prescription in Michigan through telehealth?
Yes. MCL 333.16285 lets a Michigan-licensed prescriber providing a telehealth service prescribe a non-controlled drug within scope of practice, and MCL 333.16284 requires the prescriber to get your consent, directly or indirectly, before the telehealth service. Semaglutide and tirzepatide are not controlled substances. [2] [4]
Does Michigan require consent for telehealth?
Yes. Under the Public Health Code, a health professional must obtain consent for treatment, directly or indirectly, before providing a telehealth service. The prescriber must also refer you to geographically accessible care when the prescriber considers it medically necessary, and must be available for follow-up care or refer you to another health professional for it (MCL 333.16285). [2] [4]
Can an out-of-state pharmacy ship compounded peptides to me in Michigan?
Generally only if it holds a Michigan pharmacy license. MCL 333.17748 requires any pharmacy doing business in Michigan to be licensed, whether or not it is located in the state. Check the pharmacy in the LARA license lookup before ordering. [1] [7]
Can a Michigan pharmacy compound BPC-157?
Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Michigan has no state bulks list; peptide eligibility follows the federal 503A framework. [12] [13] [14] [17] [18]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]Michigan Board of Pharmacy (LARA Bureau of Professional Licensing)
- [2]MCL 333.16285, Telehealth service; prescribing a drug
- [3]MCL 333.16283, Definitions (telehealth, telehealth service)
- [4]MCL 333.16284, Telehealth service; consent required; exception
- [5]MCL 500.3476, Telemedicine services; provisions; definitions
- [6]Mich. Admin. Code R 338.2407, Telehealth (Board of Medicine General Rules; Cornell Legal Information Institute copy)
- [7]MCL 333.17748, Pharmacy, manufacturer, or wholesale distributor license required
- [8]MCL 333.17748a, Compounding services for sterile pharmaceuticals; accreditation
- [9]Mich. Admin. Code R 338.533, Compounding standards and requirements; outsourcing facilities
- [10]Mich. Admin. Code R 338.534, Out-of-state pharmacy licensure inspection; in-state renewal inspection
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 28). Are peptides legal in Michigan?. https://peptideagent.ai/legal/michigan- HTML link
<a href="https://peptideagent.ai/legal/michigan">Are peptides legal in Michigan?</a>, PeptideAgent, updated October 28, 2026.